Tumors Associated with Histone H3 Mutations
General Pathology

Tumors Associated with Histone H3 Mutations

pathologymcqs2 min read
Clinical outcomes for H3K27M-mutant diffuse midline gliomasClinical trials for histone H3 mutation-targeted therapiesDiagnostic significance of histone H3 mutations in gliomasGenetic testing for histone H3 mutations in canceH3G34R mutations in pediatric high-grade gliomaH3K27M mutation and PRC2 inhibition in gliomasH3K27M mutation in pediatric brainstem gliomasHistone H3 mutations and tumor aggressivenessHistone H3 mutations as prognostic indicators in cancerHistone H3 mutations in chondroblastoma and treatmentHistone H3F3A mutations in giant cell tumor of bonHistone H3K27M mutation in diffuse midline gliomasHistone mutations and epigenetic dysregulation in cancerImpact of histone H3 mutations on pediatric brain tumorsMolecular heterogeneity in histone H3-mutated gliomaspathologyPrognosis for H3K27M-mutated diffuse intrinsic pontine gliomaTargeted therapies for histone H3-mutated tumorsTreatment options for H3K27M glioma

Histone H3 mutations are significant in the context of certain tumors, particularly pediatric high-grade gliomas (HGGs) and other cancers. These mutations occur in the genes encoding the histone H3 proteins, which play a crucial role in the regulation of DNA structure and function. The most common mutations involve the substitution of a single amino acid, such as the replacement of lysine with methionine at position 27 (H3K27M) or glycine with arginine at position 34 (H3G34R).

Conditions Associated with Histone H3 Mutations

Epithelioid MPNST
H3K27me loss is identified.

  • Diffuse Midline Gliomas (DMGs)
    • H3K27M Mutation: Predominantly found in DMGs, especially in the brainstem (e.g., pontine gliomas).
    • Clinical Impact: Highly aggressive, poor prognosis, primarily affects children and young adults.
  • Pediatric High-Grade Gliomas (HGGs)
    • Common Mutations: H3K27M and H3G34R/V.
    • Location: Often found in the thalamus and spinal cord (for H3K27M), and cerebral hemispheres (for H3G34R/V).
    • Prognosis: Generally poor, with distinct molecular subgroups defined by histone mutations.
  • Pediatric Low-Grade Gliomas
    • H3F3A Mutations: Less common but can occur.
    • Clinical Course: Generally better prognosis compared to high-grade gliomas.
  • Gangliogliomas
    • H3K27M Mutation: Rare but can be present.
    • Prognosis: Variable, depends on other molecular and clinical factors.
  • Ependymomas
    • H3K27M Mutation: Occasional cases, contributing to poorer prognosis.
    • Location: Frequently found in the posterior fossa and spinal cord.
  • Acute Myeloid Leukemia (AML)
    • H3 Mutations: Rare but documented, potentially impacting disease progression and treatment response.
  • Giant Cell Tumor of Bone (GCTB)
    • H3F3A Mutation: Commonly presents with G34W mutation.
    • Characteristics: Benign but locally aggressive, often affecting the epiphyses of long bones in young adults.
  • Chondroblastoma
    • H3F3B Mutation: Typically presents with K36M mutation.
    • Features: Rare, benign bone tumor, usually in the epiphyses of long bones in adolescents and young adults.

Try to answer this question : Which of the following tumors are associated with loss of H3K27me loss?

Correct answer is A: Malignant peripheral nerve sheath tumor (MPNST)

For more MCQs like these

/blog/product/neet-ss-dm-oncopathology-course/
/blog/product/frcpath-histopathology-part-1-course/

Related articles